Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

Adolescents and young adults have unique needs, and this research highlights financial and social vulnerabilities of young people with cancer,” said Brittany C. Kimball, MD.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

Adherence to American Cancer Society guidelines linked to lower mortality in nonsmoking survivors of obesity-related cancer.